 | Are Institutions Heavily Invested In BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) Shares?
finance.yahoo.com - January 14 at 6:06 PM |
 | BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) CEO Jon P. Stonehouse Sells 184,000 Shares
insidertrades.com - January 13 at 6:48 PM |
 | Why BioCryst Pharmaceuticals Stock Is Skyrocketing This Week
fool.com - January 13 at 4:57 PM |
| BioCryst Pharmaceuticals (NASDAQ:BCRX) Stock Price Up 12.7%
americanbankingnews.com - January 12 at 12:48 PM |
 | BioCryst Is On Fire: What Do Options Traders Expect Next?
msn.com - January 12 at 10:32 AM |
 | Biocryst Pharmaceuticals Inc. Shares Close the Day 11.2% Higher - Daily Wrap
nasdaq.com - January 12 at 1:53 AM |
| BioCryst Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:BCRX)
americanbankingnews.com - January 11 at 6:32 PM |
| BioCryst Stock at $21 a Share? This Analyst Thinks It’s Possible
finance.yahoo.com - January 11 at 3:52 PM |
| BioCryst Pharmaceuticals (NASDAQ:BCRX) Receives "Buy" Rating from HC Wainwright
americanbankingnews.com - January 11 at 1:36 PM |
| BioCryst Pharmaceuticals (NASDAQ:BCRX) Sees Strong Trading Volume
americanbankingnews.com - January 11 at 12:20 PM |
| Why BioCryst Pharmaceuticals Stock Is Jumping on Monday
finance.yahoo.com - January 10 at 2:55 PM |
|
| BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Gap Up to $11.56
americanbankingnews.com - January 10 at 11:38 AM |
 | BioCryst sees Q4 Orladeyo revenue of $45.6M
seekingalpha.com - January 10 at 9:55 AM |
| BioCryst Announces Preliminary Full Year 2021 ORLADEYO® (berotralstat) Net Revenue and Provides Full Year 2022 ORLADEYO Net Revenue and Peak Sales Guidance
finance.yahoo.com - January 10 at 9:55 AM |
| Swelling losses haven't held back gains for BioCryst Pharmaceuticals (NASDAQ:BCRX) shareholders since they're up 85% over 5 years
nasdaq.com - January 9 at 9:07 AM |
| BioCryst begins patient enrollment in REDEEM-1 trial of BCX9930 for rare blood disorder
seekingalpha.com - January 7 at 1:21 PM |
| BioCryst Begins Patient Enrollment in REDEEM-1 Pivotal Trial Evaluating BCX9930 as Oral Monotherapy for Patients with PNH
finance.yahoo.com - January 7 at 1:21 PM |
| BioCryst to Present at 40th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 10:09 AM |
| There’s an Opportunity Brewing in BioCryst Stock, Says Analyst
finance.yahoo.com - December 15 at 1:56 PM |
| BioCryst (BCRX) Begins Enrollment in PNH Study on BCX9930
finance.yahoo.com - November 30 at 2:15 PM |
| Insider Buying: The BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Senior VP & CFO Just Bought 60% More Shares
finance.yahoo.com - November 30 at 9:14 AM |
| BioCryst Begins Patient Enrollment in REDEEM-2 Pivotal Trial Evaluating BCX9930 as Oral Monotherapy for Patients with PNH
finance.yahoo.com - November 29 at 9:08 AM |
| Insider Buying: The BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Director Just Bought 75% More Shares
nasdaq.com - November 26 at 1:06 AM |
 | Thinking about buying stock in Innoviz Technologies, Avaya Holdings, BioCryst Pharmaceuticals, Lithium Americas Corp, or FuelCell Energy?
benzinga.com - November 23 at 9:54 AM |
| BioCryst Adds $350 Million in New Financing with Royalty Pharma and OMERS Capital Markets
finance.yahoo.com - November 22 at 8:14 AM |
| BioCryst Adds $350 Million in New Financing with Royalty Pharma and OMERS Capital Markets
finance.yahoo.com - November 22 at 8:14 AM |
| Royalty Pharma Acquires Additional Royalty Interests in BCX9930 and ORLADEYO from BioCryst Pharmaceuticals
finance.yahoo.com - November 22 at 8:14 AM |
| BioCryst: Orladeyo on Track to Reach Top of the HAE Market
finance.yahoo.com - November 5 at 7:41 AM |
| BioCryst Presents New Data Showing Sustained Reduction of HAE Attack Rates and Improved Patient Satisfaction After Patients Switch to ORLADEYO® (berotralstat)
finance.yahoo.com - November 5 at 7:41 AM |
| BioCryst Pharmaceuticals Becomes Oversold (BCRX)
nasdaq.com - November 4 at 4:30 PM |
| Insiders are probably glad they sold their shares in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) after 17% drop
nasdaq.com - November 4 at 9:14 AM |
| BCRX Makes Notable Cross Below Critical Moving Average
nasdaq.com - November 3 at 6:12 PM |
| BioCryst Pharmaceuticals (BCRX) Q3 2021 Earnings Call Transcript
finance.yahoo.com - November 3 at 6:12 PM |
| Here's Why BioCryst Pharmaceuticals Stock Is Losing Ground Today
fool.com - November 3 at 1:34 PM |
|
| BioCryst Reports Third Quarter 2021 Financial Results and Upcoming Key Milestones
finance.yahoo.com - November 3 at 8:11 AM |
| BioCryst Appoints Jinky Ang Rosselli Chief Data and Insights Officer
finance.yahoo.com - November 1 at 11:05 AM |
| BioCryst to Present New ORLADEYO® (berotralstat) Data at Annual Scientific Meeting of American College of Allergy, Asthma & Immunology
finance.yahoo.com - October 26 at 8:56 AM |
| Do Hedge Funds Love BioCryst Pharmaceuticals, Inc. (BCRX)?
finance.yahoo.com - October 25 at 8:21 PM |
| BioCryst to Report Third Quarter 2021 Financial Results on November 3
finance.yahoo.com - October 20 at 10:32 AM |
| 2 Super-Charged Growth Stocks to Buy Now
finance.yahoo.com - October 13 at 10:35 AM |
| First Week of November 19th Options Trading For BioCryst Pharmaceuticals (BCRX)
nasdaq.com - October 6 at 1:57 PM |
| 3 Biotech Stocks Wall Street Thinks Could Rise 44% or Better
finance.yahoo.com - September 30 at 8:07 AM |
| BCRX Oct 2021 12.000 put
finance.yahoo.com - September 29 at 4:45 PM |
| BioCryst to Present at 2021 Cantor Virtual Healthcare Conference
finance.yahoo.com - September 21 at 9:30 AM |
| BioCryst Appoints Dr. Amy McKee to Board of Directors
finance.yahoo.com - September 20 at 8:20 AM |
| NICE Recommends BioCryst's Hereditary Angioedema Med
finance.yahoo.com - September 16 at 5:52 PM |
| U.K's NICE Recommends BioCryst's Orladeyo To Prevent Attacks In HAE Patients
nasdaq.com - September 16 at 1:37 AM |
| NICE Recommends BioCryst’s ORLADEYO® (berotralstat), the First Oral, Once-daily Therapy, to Prevent Attacks in HAE Patients in the UK
finance.yahoo.com - September 15 at 8:36 PM |
| First Week of BCRX January 2024 Options Trading
nasdaq.com - September 14 at 8:56 PM |
| BioCryst Announces Approval of ORLADEYO® (berotralstat) in United Arab Emirates
finance.yahoo.com - September 9 at 9:35 AM |
